This study evaluates inclusion of National Comprehensive Cancer Network (NCCN) guideline recommended biomarkers for metastatic non–small cell lung cancer (NSCLC) in commercially available targeted next-generation sequencing (NGS) panels.
Siyang Peng, MS
Advertisement
Articles by Siyang Peng, MS
Advertisement
Latest Updated Articles
Do Targeted NGS Panels Include NSCLC Guideline-Recommended Biomarkers?February 12th 2026
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
Obesity, Insulin Resistance, and the Silent Progression of MASH: A Hepatologist's Perspective
4
How Portable Oxygen Is Changing Home Respiratory Care: Doug Francis
5